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Pathological alterations of the Golgi apparatus, such as its fragmentation represent
an early pre-clinical feature of many neurodegenerative diseases and have been
widely studied in the motor neuron disease amyotrophic lateral sclerosis (ALS).
Yet, the underlying molecular mechanisms have remained cryptic. In principle, Golgi
fragmentation may result from defects in three major classes of proteins: structural
Golgi proteins, cytoskeletal proteins and molecular motors, as well as proteins mediating
transport to and through the Golgi. Here, we present the different mechanisms that may
underlie Golgi fragmentation in animal and cellular models of ALS linked to mutations
in SOD1, TARDBP (TDP-43), VAPB, and C9Orf72 and we propose a novel one based
on findings in progressive motor neuronopathy (pmn) mice. These mice are mutated
in the TBCE gene encoding the cis-Golgi localized tubulin-binding cofactor E, one
of five chaperones that assist in tubulin folding and microtubule polymerization. Loss
of TBCE leads to alterations in Golgi microtubules, which in turn impedes on the
maintenance of the Golgi architecture. This is due to down-regulation of COPI coat
components, dispersion of Golgi tethers and strong accumulation of ER-Golgi SNAREs.
These effects are partially rescued by the GTPase ARF1 through recruitment of TBCE
to the Golgi. We hypothesize that defects in COPI vesicles, microtubules and their
interactionmay also underlie Golgi fragmentation in human ALS linked to other mutations,
spinal muscular atrophy (SMA), and related motor neuron diseases. We also discuss
the functional relevance of pathological Golgi alterations, in particular their potential
causative, contributory, or compensatory role in the degeneration of motor neuron cell
bodies, axons and synapses.
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INTRODUCTION
Amyotrophic Lateral Sclerosis (ALS) is a severe neurodegenerative disease characterized by
progressive degeneration of motor neurons in spinal cord, brainstem and cerebral cortex and of
their corresponding axons in the corticospinal tract and in peripheral nerves. Degeneration of
motor axons and loss of neuromuscular synapses leads to denervation of skeletal muscle fibers
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which causes progressive muscle weakness and paralysis and
becomes fatal when it reaches critical muscle groups, usually
within 2–5 years after disease onset (Robberecht and Philips,
2013).
ALS can be caused by mutations in more than 20 genes,
including the major ones SOD1, TARDBP (TDP-43), FUS and
C9ORF72, or manifest as apparently sporadic form. In ALS
motor neurons, many cellular functions are altered as illustrated
by defects in nucleocytoplasmic transport (Freibaum et al.,
2015; Jovicic et al., 2015; Zhang et al., 2015), in processing
of mRNAs (Lourenco et al., 2015) and miRNAs (Emde et al.,
2015), in formation of stress granules (Li et al., 2013), ER
stress (Matus et al., 2013), mitochondrial dysfunction (Pasinelli
et al., 2004), and alterations in almost all steps of membrane
traffic. For instance, autophagy (Ferrucci et al., 2011; Song et al.,
2012; Majcher et al., 2015), endocytosis (Rusten and Simonsen,
2008), and secretory function (Gonatas et al., 1998; Nassif et al.,
2010) have been shown to be affected. In this review, we
will focus on structural and functional alterations of the Golgi
apparatus.
The Golgi apparatus is a unique organelle comprising stacks
of flattened discrete membrane-bound compartments called
cisternae forming the so-called Golgi stacks. In mammalian
cells, these stacks are laterally connected by tubules to form a
large Golgi ribbon capping the nucleus (Figure 1A) and (Képès
et al., 2005; Glick and Nakano, 2009). Furthermore, the Golgi
apparatus is polarized with a cis-entry site facing the ER and
the ERGIC (ER-Golgi intermediate compartment) and a trans-
exit face facing the endosomal system (Polishchuk and Mironov,
2004). In motor neurons, the Golgi apparatus forms a very large
network that extends into axons and dendrites (Bellouze et al.,
2014; Valenzuela and Perez, 2015).
In motor neurons of ALS patients, the Golgi apparatus
often appears either fragmented, i.e., transformed into multiple
disconnected elements or tubular-vesicular clusters, or atrophied,
i.e., reduced in its membrane content (Mourelatos et al., 1990;
Gonatas et al., 1992). These pathological changes are detectable
in all types of motor neurons located in spinal cord, brainstem
and cerebral cortex (Mourelatos et al., 1996; Fujita et al., 1999,
2000). Furthermore, they are common to both sporadic (Gonatas
et al., 1992) and familial (Mourelatos et al., 1996; Fujita et al.,
1999, 2000) forms of the disease, including ALS with Bunina
bodies (Stieber et al., 1998), juvenile ALS (Fujita et al., 2002),
and ALS with posterior column involvement (Fujita et al.,
2000).
Golgi fragmentation has been found to be closely associated
with other neuropathological hallmarks of ALS, such as
cytoplasmic basophilic inclusions (Fujita et al., 2002), ubiquitin
aggregates (Vlug et al., 2005), SOD1 aggregates (Fujita et al.,
2000) and TDP-43 pathology (Fujita et al., 2008). Importantly,
Golgi alterations occur at an early preclinical stage in human
ALS patients (Maruyama et al., 2010) and in rodent ALS models
(Mourelatos et al., 1996; Vlug et al., 2005; Tong et al., 2012; van
Dis et al., 2014), suggesting that Golgi fragmentation precedes
the degenerative loss of motor neuron cell bodies and axons. By
contrast, conspicuous Golgi alterations in motor neurons are not
observed after chemical poisoning (Mourelatos et al., 1994) or
axonal injury (Bellouze et al., 2014), ruling out that they are a
mere consequence of neuronal damage.
The main function of the Golgi apparatus in healthy
cells is to ensure the processing (enzymatic modification
and proteolytic cleavage) and sorting of proteins from their
site of synthesis in the endoplasmic reticulum to their
final destination, plasma membrane, extracellular space and
endosomal/lysosomal compartments (Bonifacino and Glick,
2004). The Golgi apparatus also ensures the polarity of protein
and lipid transport to axons and dendrites (Tang, 2001; Ramírez
and Couve, 2011; Bonifacino, 2014). In particular, the Golgi
apparatus is required for the assembly and axonal transport of
synaptic vesicle precursors (Maas et al., 2012). Alterations of the
Golgi apparatus could therefore be accompanied by loss or gain
of function in protein sorting, processing and transport to the
axons and synapses, leading to their degeneration. Furthermore,
Golgi fragmentation leads to activation of apoptotic pathways
(Hicks and Machamer, 2005; Machamer, 2015) that can
contribute to axonal degeneration and ultimately to cell death.
Despite their early occurrence and high frequency, the precise
relevance of these pathological Golgi alterations remains unclear.
Future studies have to clarify whether they have a causative,
contributory or homeostatic role in motor neuron degeneration,
in particular with respect to the loss of cell bodies, axons and
synapses. To be able to address this in a meaningful manner, it
is crucial to better understand the precise mechanisms of Golgi
pathology in ALS.
THREE CLASSES OF PROTEINS ARE
IMPORTANT FOR GOLGI MAINTENANCE
In theory, Golgi morphology depends on three classes of proteins:
The microtubules (MTs) and MT-associated motor proteins; the
structural Golgi proteins; and the proteins of the Golgi transport
machinery. Of note, most of the knowledge on these alterations
comes from studies in mitotic non-neuronal cells and only few
data are available from motor neurons.
The Microtubule Cytoskeleton
It has been known for 30 years that microtubule
depolymerization (for instance with nocodazole or colchicine)
alters the Golgi morphology of mammalian cells. Instead of the
single copy organelle capping the nucleus in non-treated cells,
the Golgi ribbon appears fragmented leading to single stacks or
group of stacks (Ellinger and Pavelka, 1984; Rogalski and Singer,
1984; Turner and Tartakoff, 1989; Cole et al., 1996; Scales et al.,
1997).
It is also increasingly recognized that in addition to the
centrosome, the Golgi is a major site of microtubule formation in
various cell types (Chabin-Brion et al., 2001; Efimov et al., 2007;
Miller et al., 2009), including hippocampal neurons (Stiess et al.,
2010; Yau et al., 2014) and motor neurons (Bellouze et al., 2014),
see for review (Zhu and Kaverina, 2013; Rios, 2014; Kapitein and
Hoogenraad, 2015; Sanders and Kaverina, 2015).
During neuronal differentiation, the centrosome is
dismantled and becomes dispensable for the formation of
microtubules and for the establishment of proper axonal
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FIGURE 1 | The Golgi apparatus in wild type motor neurons. (A) An electron micrograph showing part of the typical Golgi ribbon in a mouse lumbar spinal cord
motor neuron. (B) Schematic representation of some of the molecular players involved in the organization of the wild type Golgi. Polymerization of microtubules (MT) at
the cis-Golgi depends on TBCE which mediates cross talk with ARF1-mediated COPI vesicle biogenesis [box 1]. Golgi microtubules nucleated by GCC185/CLASPs
at the trans-Golgi play a role in Golgi ribbon linking [box 2]. The formation of the Golgi ribbon at the cis side is mediated by the tethering complex GRASP65/GM130
[box 3]. COPI vesicle fusion is mediated by the tethering complex p115/GM130 and SNARE complexes containing GS15, GS28, and Syntaxin 5 [box4].
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and neuronal morphology (Basto et al., 2006; Stiess et al.,
2010; Nguyen et al., 2011). The Golgi however expands
and rearranges (Horton et al., 2005) and may thus become
increasingly for the correct formation, nucleation and dynamics
of microtubules.
The formation of microtubules involves the folding of alpha-
and beta-tubulins, their dimerization and polymerization. The
last steps of this complex process are assisted by five tubulin-
specific chaperones termed tubulin-binding cofactors TBCA-
TBCE (Tian et al., 1996, 1997). Among these, TBCE is expressed
at high levels in motor neurons (Schaefer et al., 2007) where it
is associated to the cis-Golgi (Figure 1B) and is critical for the
polymerization of Golgi-derived microtubules (Bellouze et al.,
2014). The nucleation of Golgi-microtubules then involves the
Golgi proteins GM130 (Kodani and Sütterlin, 2008), AKAP-
450 (Rivero et al., 2009), and CLASP1/2 (Efimov et al., 2007)
(Figure 1B).
The Golgi Structural Proteins
The second class of proteins that could be affected are the so-
called Golgi structural proteins. These are the Golgins, extended
coiled-coil proteins that form a proteinaceous matrix around the
Golgi (Munro, 2011; Gillingham et al., 2014). Their knock down
leads to a structural alteration of the Golgi. This is the case for
p115, GM130, but also Golgin 84 (Diao et al., 2003) and Giantin
(Koreishi et al., 2013). In addition, two non-Golgin proteins have
been shown to be critical for the Golgi architecture, GRASP65
and 55 with a role in the formation of tubular connections
between Golgi stacks to form the Golgi ribbon (Vinke et al.,
2011; Jarvela and Linstedt, 2012, 2014; Veenendaal et al., 2014;
Figure 1B) as well as in cisternal stacking (Xiang and Wang,
2010). Of note, it is sometimes difficult to tease apart the strict
role of these proteins in Golgi structure from their role in
trafficking thus precisely pin-pointing the primary cause for
Golgi fragmentation.
Interestingly, some of these proteins are the targets of
specific modifications that occur at the onset of mitosis
when the Golgi becomes physiologically fragmented in a
controlled and reversible manner. For instance, GM130 is
phosphorylated, leading to dissociation of the GM130/p115
complex. As a result, COPI vesicles are no longer tethered
and cannot fuse, leading to Golgi fragmentation and generation
of mitotic clusters (Nakamura et al., 1997). Furthermore,
GM130 (Walker et al., 2004), p115 (Chiu et al., 2002), and
GRASP65 (Lane et al., 2002; Cheng et al., 2010) are targets
of apoptotic caspase-mediated proteolysis leading to Golgi
fragmentation.
The Golgi Transport Machinery
The third class of proteins that, when altered, could lead to a loss
of the typical Golgi architecture are the proteins functioning in
the traffic between the ER and the Golgi, especially COPI and
COPII coat complexes as well as their tethering/docking/fusion
machinery. Trafficking between the ER and the Golgi is mediated
by at least two coat complexes.
The COPII coat assembles at specific sites of the ER, called
ER exit sites, where COPII coated vesicles form and bud (Miller
and Schekman, 2013; Sprangers and Rabouille, 2015). The COPI
complex or coatomer assembles at the surface of the Golgi and
the ERGIC. The coatomer comprises 6 structural subunits alpha,
beta, beta’, delta, gamma, and epsilon COP (Beck et al., 2009) and
their formation requires the small GTPase Arf1 and its GEFGBF1
(Popoff et al., 2011). There is a strong consensus that COPI coated
vesicles mediate the retrograde transport from the Golgi to the
ER, but it is also possible that they may also participate in specific
anterograde transport steps from the ERGIC to the cis Golgi
cisterna and/or within the Golgi cisternae (Aguilera-Gomez and
Rabouille, 2015).
After budding from their respective compartments, the COPI
and COPII coated vesicles fuse with their target compartments
and this requires tethering (p115/GM130), docking (using Rab
proteins, Pfeffer, 2013a,b) and fusion proteins, such as the
SNAREs. The SNAREs are type II c-tail anchored transmembrane
proteins with almost all their mass in the cytoplasm. They belong
to two classes, v-SNAREs (present on vesicles) and t-SNAREs
(present on target compartments), roughly corresponding to R-
and Q-SNAREs. Usually, three Q-SNAREs and one R-SNARE
form a tight parallel helix that mediates vesicle fusion (Malsam
and Söllner, 2011).
Impairment of the balance between vesicle budding and
fusion either at the Golgi or the ER leads to a loss of Golgi
architecture and its complete vesiculation. For instance, when
COPII vesicle budding is inhibited, the Golgi vesiculates (Prescott
et al., 2001). The Golgi appears similarly vesiculated when
COPI formation is impaired by BFA treatment or depletion
of COPI subunits (Guo et al., 2008; Razi et al., 2009). Last,
impaired Golgi SNARE function like depletion of Syntaxin 5
(Suga et al., 2005) also leads to strong Golgi fragmentation, as
observed in cellular models of Parkinson disease (Rendón et al.,
2013).
Furthermore, at least one caspase (caspase 2) is localized
to the Golgi (O’Reilly et al., 2002), suggesting that the
Golgi can sense cell death signals and transduce them
via cleavage of structural Golgi proteins (Galluzzi et al.,
2014).
PROPOSED TRIGGERS OF GOLGI
FRAGMENTATION IN ALS AND RELATED
MOTOR NEURON DISEASES
The precise mechanisms of Golgi fragmentation in degenerating
motor neurons are not fully understood but first insights
arise from studies in animal and cellular models of ALS and
related motor neuron diseases linked to mutations in SOD1,
Dynein/Dynactin, TARDBP (TDP-43), and VAP-B.
Schematically, four mechanisms of Golgi fragmentation can
be distinguished: The first one involves defective microtubules or
microtubule-dependent transporters due to mutations in SOD1
(Soo et al., 2015), Dynein/Dynactin (Hafezparast et al., 2003;
Puls et al., 2003), and BICD2 (Neveling et al., 2013; Peeters
et al., 2013). Dynein and BICD2 will not be discussed further
as two excellent reviews have just been published on that topic
(Jaarsma and Hoogenraad, 2015; Wirth and Martinez-Carrera,
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2015). The second one postulates the cleavage of Golgi structural
proteins by activation of caspases (SOD1). The third and fourth
ones hypothesize that Golgi fragmentation is due to toxic protein
aggregates (TDP-43, SOD1) or dysfunctional proteins (VAP-B),
which potentially impair trafficking within the early secretory
pathway.
Here, we first summarize these data before describing a novel
mechanism that involves both microtubules, Golgi vesicles and
structural Golgi proteins, and which is potentially shared by
several forms of human ALS, spinal muscular atrophy (SMA),
and related motor neuron diseases.
Microtubule Disruption by Mutant SOD1
Mutations in the human SOD1 (Cu/Zn superoxide dismutase 1)
gene account for ∼5% of familial forms of ALS (Andersen and
Al-Chalabi, 2011) and are at the origin of the most widely used
animal and cellular models of ALS. Transgenic mice expressing
ALS-linked SOD1 mutations manifest signs of motor neuron
degeneration such as early axonal dying back and loss of
neuromuscular synapses (Fischer et al., 2004; Schaefer et al., 2005;
Pun et al., 2006). In these mice, Golgi fragmentation occurs at an
early preclinical stage and precedes most other histopathological
alterations (Mourelatos et al., 1996; Vlug et al., 2005; van Dis
et al., 2014).
Earlier studies suggested that mutant SOD1-linked Golgi
fragmentation may originate from microtubule alterations.
Indeed, the mean diameter of Golgi cisternae was found to
be shorter in mice overexpressing mutant SOD1 G93A when
compared to those expressing wildtype SOD1 (Gonatas et al.,
1992), an effect similar to that of themicrotubule-disrupting drug
colchicine (Mourelatos et al., 1990). A recent study further shows
that cellular overexpression of mutant SOD1 is associated with
unstable microtubules and decreased levels of acetylated tubulins
(Soo et al., 2015).
Furthermore, the microtubule-severing protein Stathmin-1
of the Stathmin family that regulates microtubule transition
from growing to shrinking phases, some of which are also
associated with the Golgi membrane (Gavet et al., 1998) has
been found to be up-regulated both at the RNA (Ferraiuolo
et al., 2007) and the protein (Strey et al., 2004) level in
mutant SOD1-expressing mouse motor neurons. Finally, the
most acidic isoform of Stathmin-1, which probably corresponds
to the inactive phosphorylated protein, was found selectively
down-regulated (Strey et al., 2004).
However appealing, this hypothesis is not yet proven since
no conspicuous microtubule alterations have been detected in
mutant SOD1 motor neurons with a fragmented Golgi following
standard tissue preparation (Strey et al., 2004). To detect SOD1-
triggered microtubule alterations in vivo, better techniques for
microtubule preservation and visualization such as high pressure
freezing and EM-based 3D reconstruction (Marsh et al., 2001)
may be required. To firmly establish the role of Stathmin-
1 and the related Stathmins 2–4 as potential mediators of
mutant SOD1-triggered Golgi pathology, it will be necessary
to recapitulate Golgi fragmentation by Stathmin overexpression
and to rescue mutant SOD1-linked Golgi fragmentation by
Stathmin knock down.
Caspase-mediated Cleavage of Structural
Golgi Proteins by Mutant SOD1
Mutant SOD1-linked Golgi fragmentation in motor neurons
may involve defects in structural Golgi proteins that have been
shown to be targets of caspases as described above. We have
previously shown that mutant SOD1 sensitizes motor neurons to
Fas-triggered cell death involving caspases 8 and 3 (Raoul et al.,
2002, 2006). Additional studies have shown that caspases 1, 3,
9, and 12 are activated in mutant SOD1 spinal cord (Li et al.,
2000; Inoue et al., 2003; Kikuchi et al., 2006). Whether mutant
SOD1 triggers caspase-cleavage of Golgi proteins and thereby
contributes to Golgi fragmentation in motor neurons remains
however to be investigated.
Protein Aggregates and Golgi
Fragmentation: TDP-43
Typical ALS is characterized by cytoplasmic inclusions made
of irreversible protein aggregates comprising the nuclear
transactivation response (TAR) DNA-binding protein of 43-
kDa (TDP-43; Neumann et al., 2006). Furthermore, TARDBP
(TDP-43) mutations are associated with sporadic and familial
forms of ALS (Sreedharan et al., 2008; Van Deerlin et al.,
2008) and were reported to form cytosolic protein aggregates
in human postmortem tissues (Lee et al., 2012) and in iPSc-
derived motor neurons (Egawa et al., 2012) of patients. The TDP-
43 protein aggregates occur in many, albeit not all, neuronal
types in patients (Toyoshima and Takahashi, 2014) and in
animal models (Tsao et al., 2012). The formation of these
inclusions is thought to impair TDP-43 critical nuclear function
in neuronal RNAmetabolism, including the splicing and stability
of numerous RNAs encoding proteins involved in neuronal
development, synaptic function and neurodegeneration (Lagier-
Tourenne et al., 2012; Jovicic and Gitler, 2014; Lee et al.,
2015; Ludolph and Brettschneider, 2015; Scotter et al., 2015;
Smethurst et al., 2015). Thus, a loss of these functions through
cytoplasmic irreversible protein aggregation is an attractive
hypothesis regarding the role of TDP-43 in neurodegeneration
(Dewey et al., 2012).
Interestingly, the presence of TDP-43 positive cytoplasmic
inclusions has been associated with Golgi fragmentation in
spinal motor neurons of ALS patients (Fujita et al., 2008).
Similarly, in transgenic rats overexpressing mutant human TDP-
43, Golgi fragmentation is detected in a concomitant manner
with the formation of TDP-43 aggregates (also positive for
ubiquitin) in the same neuron (Tong et al., 2012). Whether and
how cytoplasmic TDP-43 protein aggregates are mechanistically
linked to Golgi fragmentation is however not known, and the
potential Golgi targets and stress signaling pathways of TDP-43
inclusions remain to be identified.
Golgi Fragmentation Due to Impairment in
the Early Secretory Pathway Trafficking
Aggregated SOD1 and Golgi Fragmentation
Overexpressed mutant SOD1 in CHO cells is also shown to
aggregate, thus trapping key proteins of the early secretory
pathway (see below Atkin et al., 2014). In contrast, mutant
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SOD1 is seen diffuse in the cytoplasm in Neuro2a cells but its
aggregation is triggered upon overexpression of chromogranins,
components of neurosecretory vesicles. Interestingly, this
aggregation pattern is consistent with the Golgi/TGN that
appears disrupted in large vesicles (Urushitani et al., 2006),
a result that can be explained by the interaction between
chromogranins and mutant SOD1.
This suggests that mutant SOD1 is recruited to the Golgi
through its interactions with chromogranins. This could be
consistent with an association of SOD1 on the cytoplasmic leaflet
of the Golgi membrane, but the authors show that mutant
SOD1 is secreted to the extracellular medium together with the
chromogranins. This suggests that mutant SOD1 has somehow
reached the lumen of these large vesicles, an event proposed
to occur early in the early secretory pathway (Urushitani
et al., 2008). In this specific case, however, the observed Golgi
disruption is not due to expression of mutant SOD1, but to
the co-expression of chromogranins. The mechanism for the
chromogranin-mediated mutant SOD1 translocation remains to
be elucidated.
Several studies also indicate that misfolded mutant forms of
SOD1 can impede ER-to-Golgi transport (Stieber et al., 2004).
Indeed, using NSC-34 motor neurons cell in culture, expression
of mutant SOD1 was shown to first inhibit ER-Golgi trafficking,
an event that preceded ER stress (Turner and Atkin, 2006;
Atkin et al., 2014), and Golgi fragmentation. Interestingly, four
different mutant forms of SOD1 (but not wildtype SOD1) have
been shown to bind the COPII subunit Sec23 that co-localizes
with aggregated mutant SOD1. This presumably renders it non-
functional (Atkin et al., 2014) and leads to Golgi fragmentation
that was rescued upon overexpression of the small GTPase
Sar1. The interaction between mutant SOD1 and Sec23 was also
reported in SOD1 mouse spinal cord at the early age of 10 days.
These findings may thus link Golgi fragmentation to the early
disruption of ER exit in mutant SOD1 expressing cells (Atkin
et al., 2014).
Loss VAP-B Induces Golgi Fragmentation
Atypical forms of familial ALS (ALS8) and late-onset SMA have
been associated with a dominant missensemutation (P56S) in the
VAPB gene (Nishimura et al., 2004, 2005; Marques et al., 2006;
Funke et al., 2010). Additional VAP-B mutations have reported
been in few patients with typical ALS (Kabashi et al., 2013).
VAP-B and its homolog VAP-A are members of the highly
conserved and ubiquitously expressed VAP (Vesicle-Associated
Membrane Protein (VAMP)-Associated Protein) family of ER C-
tail anchored proteins. This class of proteins has been shown
to interact with the FFAT motif (two phenylalanines in an
acidic tract) characteristic of lipid transfer proteins enriched
at membrane contact sites between the ER and the Golgi
(Mesmin et al., 2013) and other organelles (Levine and Loewen,
2006). In addition, VAP proteins seem implicated in membrane
trafficking, ER/cytoskeleton interactions, the unfolded protein
response (reviewed in (Lev et al., 2008), calcium homeostasis
(De Vos et al., 2012; Stoica et al., 2014), axonal transport of
mitochondria (Mórotz et al., 2012) as well as neurite extension
and neurotransmitter release (Saita et al., 2009; Ohnishi et al.,
2014).
When overexpressed, the ALS-linked VAP-B mutant P56S
favors the formation of clusters of paired ER cisternae (Fasana
et al., 2010; Kuijpers et al., 2013b) that are located close to the
Golgi (Genevini et al., 2014). This leads to ER stress and disrupts
ER to ERGIC to Golgi trafficking (Kuijpers et al., 2013b). It also
causes Golgi fragmentation in a small number (15%) of primary
rat hippocampal neurons (Teuling et al., 2007), although this was
not observed (albeit not quantified) in spinal motor neurons on
sections (Kuijpers et al., 2013a) or in cell culture (Genevini et al.,
2014).
One reason is that overexpression of P56S VAP-B does not
completely recapitulate the ALS situation. In fact, P56S VAP-
B leads to the degradation of wildtype VAP-B (and probably
VAP-A) and a consequent reduced level of the functional protein
(Suzuki et al., 2009; Papiani et al., 2012) but not the formation of
aberrant ER structures. Similarly, the endogenous mutant P56S
allele causes a reduction of VAP-B levels in patient-derived iPSc
motor neurons (Mitne-Neto et al., 2011) and its fly equivalent
P58S leads to aggregation of wildtype VAP-B (Ratnaparkhi
et al., 2008). This is also observed in Vapb P56S knockin mice
(Larroquette et al., 2015) where cleaved ubiquitinated VAP-B
accumulates in insoluble complexes.
Loss of VAP-B function may also be involved in other forms
of ALS since reduced VAP-B levels have been reported in the
spinal cord of mutant SOD1 mice and of patients with sporadic
ALS (Teuling et al., 2007; Anagnostou et al., 2010). Furthermore,
overexpression of VAP-B P56S inmice leads to pathological TDP-
43 aggregates both in the nucleus and the cytoplasm of motor
neurons (Tudor et al., 2010), which, as reported above, may
contribute to disruption of ER to Golgi transport.
Importantly, VAP-B depletion in HeLa cells leads to strong
Golgi fragmentation (Peretti et al., 2008). This is likely due to
the pleiotropic effects of VAP-B on Golgi-mediated transport
pathways (Peretti et al., 2008) where it interacts with numerous
Golgi-associated proteins (Huttlin et al., 2015) and microtubules
(Skehel et al., 2000). ER stress and autophagy (Larroquette et al.,
2015) may be further involved in pathogenesis.
A NOVEL MECHANISM OF GOLGI
FRAGMENTATION: DEFECTIVE CROSS
TALK BETWEEN THE MICROTUBULE
NETWORK AND COPI VESICLES
Progressive Motor Neuronopathy (pmn)
Recently, studies in pmn mice carrying a missense mutation in
the tubulin-binding cofactor TBCE have led to the elucidation
of a mechanism where microtubules, structural Golgi proteins
and the Golgi transport machinery are altered, and illustrated
a molecular cross talk between these three classes of proteins
(Bellouze et al., 2014). Loss of TBCE function in pmnmice causes
axonal dying back of motor neurons (Schaefer et al., 2007) and
loss of cochlear outer hair cells (Rak et al., 2013), growth and
mental retardation in human patients with Sanjad-Sakati/Kenny-
Caffey syndrome (Parvari et al., 2002) and impaired development
of motor axons and neuromucular synapses in Drosophila (Jin
et al., 2009). Both the TBCE pmn mutation, which leads to
protein destabilization and degradation (Martin et al., 2002;
Frontiers in Neuroscience | www.frontiersin.org 6 December 2015 | Volume 9 | Article 448
Haase and Rabouille Golgi Fragmentation in Motor Neurons
Schaefer et al., 2007), and cellular TBCE depletion (Bellouze
et al., 2014) result in a general loss of microtubules including
Golgi-derived ones.
Mutant pmn mice display clear signs of Golgi fragmentation
in lumbar spinal motor neurons at 10 days of age i.e., 5 days
before first clinical, electrical or pathological signs of axon
degeneration (Schmalbruch et al., 1991; Kennel et al., 1996;
Bellouze et al., 2014), confirming the early preclinical occurrence
of structural Golgi alterations. During disease course, Golgi
membranes are progressively transformed into vesicles and
tubules (Figure 2A) and the percentage of motor neurons with
signs of Golgi fragmentation increases massively (Bellouze et al.,
2014).
Biochemical andmicroscopic analysis of pmn associated Golgi
defects shows three critical aspects of Golgi fragmentation: a
strong decrease in the protein levels of the beta and epsilon
COPI vesicle subunits, a dispersion of the Golgi tethers p115
and GM130 away from Golgi membrane and an about 15-
fold increase in the protein levels of Golgi v-SNAREs GS15
and GS28 (Bellouze et al., 2014). This accumulation is due to
protein stabilization rather than transcriptional up-regulation,
and is nevertheless associated with compromised formation of
v-/t-SNARE complexes (Bellouze et al., 2014; Figure 2B).
Taken together, loss of TBCE leads to loss of Golgi-associated
microtubules, a fragmented Golgi and associated molecular
defects reported above. This suggests that defects in TBCE-
mediated microtubule polymerization at the Golgi impede the
COPI coat assembly that in turn causes mislocalization of
associated tethers and accumulation of Golgi SNAREs resulting
in Golgi fragmentation. This scenario of Golgi fragmentation
is further supported by reports showing that depletion of β-
COP causes accumulation of small vesicles containing Golgi
enzymes at the cell center (Guo et al., 2008) and redistribution of
GM130 (Razi et al., 2009), potentially through dysfunction of the
ER/Golgi intermediate compartment (ERGIC; Horstmann et al.,
2002; Xu and Hay, 2004).
Intriguingly, COPI dynamics feeds back on microtubule
polymerization at the Golgi. Expression of constitutionally active
GTP-locked ARF1 following TBCE knock down (not knock
out) stimulates recruitment of remaining TBCE to the Golgi,
polymerization of microtubules and rescue of the Golgi defects
(Bellouze et al., 2014). This may be due to an interaction between
Arf1 and TBCE, at least upon overexpression of both proteins,
making TBCE an Arf1 effector. We therefore propose that the
cross talk betweenmicrotubules in the cell soma andCOPI vesicle
dynamics at the Golgi maintains the Golgi structure and that the
interruption of this cross talk causes microtubule disruption and
Golgi fragmentation observed in pmnmice.
Other Mouse Mutants with Motor Neuron
Degeneration
Is the interruption of the cross talk also the mechanism of Golgi
fragmentation in other disease models? Microtubule and COPI
defects may indeed contribute to Golgi fragmentation in mdf
(muscle deficient)micemutated in the Scyl1 gene. Scyl1 encodes a
protein that normally interacts with α-COP and β-COP (Burman
et al., 2008, 2010), suggesting that Golgi fragmentation in motor
neurons of mdf mice involves defective COPI vesicle formation
which may interrupt the COPI/MT cross talk with ensuing Golgi
fragmentation.
Furthermore, SNARE-mediated vesicle tethering may be
defective in wobbler mice with motor neuron degeneration.
Indeed the mutant gene product VPS54 (Schmitt-John et al.,
2005) is a subunit of the Golgi-associated retrograde protein
(GARP) complex that normally tethers vesicle budding from late
endosomes to the TGN through interaction with the v-SNAREs
Syntaxin-6, Syntaxin-16, and VAMP4 (Pérez-Victoria et al., 2008;
Pérez-Victoria and Bonifacino, 2009).
Human ALS Linked to TUBA4A Mutations
Rare forms of human ALS have recently been associated with
mutations in the tubulin gene TUBA4A that encodes a major
alpha-tubulin isoform of adult spinal cord and brain (Smith
et al., 2014). In vitro overexpression of several ALS-linked
TUBA4A mutations causes severe alterations in the somatic
microtubule network (Smith et al., 2014). Additional forms of
human ALS and SMA are due to mutations in the microtubule
motors Dynein (Hafezparast et al., 2003), its regulator BICD2
(Neveling et al., 2013; Peeters et al., 2013), or in Optineurin
(Maruyama et al., 2010), a protein known to bind microtubules
and to mediate vesicle transport in the secretory pathway. So,
defectivemicrotubule-dependent transport as well as impairment
in trafficking through the Golgi may be the basis for Golgi
fragmentation in these diseases.
SMA
Defective cross talk between microtubules and COPI vesicles
may also be involved in classical SMA caused by deletion of
the SMN (Survival Motor Neuron) gene (Lefebvre et al., 1995).
Although Golgi fragmentation has not yet been reported in
SMN-linked SMA, increased levels of Stathmin-1 (see above)
are associated with microtubule loss, axon degeneration and
loss of neuromuscular synapses in mouse and cellular models
of SMA (Wen et al., 2010, 2013). Furthermore, SMN has been
shown to bind the COPI subunit α-COP and to co-traffic with
the latter in motor axons (Peter et al., 2011). Interrupting
SMN/α-COP interaction leads to SMN accumulation at the
Golgi (Ting et al., 2012), reduced neurite outgrowth and altered
growth cones (Custer et al., 2013). We therefore hypothesize
that the Golgi is fragmented in SMA mice and patients through
SMN/COPI/microtubule dysfunction.
ALS Linked to C9Orf72 Mutations
The most frequent forms of human ALS are caused by novel
GGGGCC (G4C2) hexanucleotide repeat expansions in the first
intron of the C9Orf72 gene (DeJesus-Hernandez et al., 2011;
Renton et al., 2011). Patients with this form of ALS typically
carry several hundred to more than thousand G4C2 repeats (Beck
et al., 2013; Dols-Icardo et al., 2014), although symptoms may be
caused by as few as 20 G4C2 repeats (Gómez-Tortosa et al., 2013).
According to the main current hypotheses, G4C2 repeat
expansions may cause disease through formation of G-
quadruplex RNA structures leading to nucleolar stress (Haeusler
et al., 2014), formation of nuclear RNA foci sequestering
essential RNA-binding proteins (DeJesus-Hernandez et al., 2011;
Polymenidou et al., 2012), repeat-associated non-AUG (RAN)
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FIGURE 2 | The fragmentation of the Golgi apparatus in pmn motor neurons. (A) An electron micrograph showing vesiculation of the Golgi stack in a lumbar
spinal cord motor neuron from a pmn mouse aged 35 days. (B) Schematic representation of the molecular defects leading to Golgi fragmentation. Loss of TBCE
function impedes polymerization of microtubules at the cis-Golgi [box 1] and potentially also their GCC185/CLASP-dependent nucleation at the trans-Golgi [box 2].
Levels of β-COP and ε-COP are reduced [box 1], vesicles containing high amounts of Golgi SNAREs GS15 and GS28 accumulate [box3] and tethers p115 and
GM130 disperse away from membranes [box 4].
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unconventional translation into toxic poly-dipeptides (DPRs;
Cleary and Ranum, 2013; Mori et al., 2013; Zu et al., 2013), or
by impeding nucleocytoplasmic transport (Freibaum et al., 2015;
Jovicic et al., 2015; Zhang et al., 2015).
It should be stressed that Golgi fragmentation has not yet
been reported in mutant C9Orf72-linked ALS. However, several
findings point to a role of the wildtype C9ORF72 protein in
vesicle trafficking. Indeed, bioinformatic analyses predict the
presence of DENN (differentially expressed in normal and
neoplastic cells) domains in C9Orf72 (Zhang et al., 2012; Levine
et al., 2013). DENN domains bear sequence and structural
homology with guanine nucleotide exchange factors (GEFs) for
Rab GTPases, some of which are involved in regulating vesicle
trafficking at the Golgi (Liu and Storrie, 2012). A recent study
has reported that the C9Orf72 protein asssociates with Rab1,
Rab7 and Rab11 (Farg et al., 2014). In addition to impairment of
autophagy and endocytic trafficking upon C9ORF72 knockdown,
the GM130 pattern is altered potentially consistent with Golgi
alterations (Farg et al., 2014).
Since gain of function rather than loss of functionmechanisms
appear to drive motor neuron degeneration in C9Orf72-linked
ALS (Koppers et al., 2015), future studies need to address the
toxic consequences of G4C2 repeat expansions and DPRs on
vesicle trafficking and maintenance of the Golgi apparatus. The
G4C2 repeat expansions can be associated with the formation of
TDP-43 nuclear and cytoplasmic inclusions (Mori et al., 2013;
but see Al-Sarraj et al., 2011), which possibly affects ER to Golgi
transport. In addition, the C9Orf72 ALS-associated DPR Gly-
Ala has recently been shown to sequester the cargo adaptor
Unc119/HRG4 into protein aggregates (May et al., 2014). This
may disrupt the ternary complex that is normally formed by
Unc119/HRG4, the tubulin-binding co-factor D (TBCD) and the
ARF-subfamily member ARL2 (Veltel et al., 2008; Ismail et al.,
2012). These data suggest that defects in the MT/COPI cross talk
may be implicated in this frequent form of human ALS.
WHAT IS THE RELEVANCE OF GOLGI
FRAGMENTATION TO MOTOR NEURON
DEGENERATION?
While Golgi fragmentation is now recognized as an early
and constant hallmark of degenerating motor neurons in ALS
and related motor neuron diseases, its relationship to the
neurodegenerative process remains to be clarified. Numerous
studies indicate that structural and functional Golgi alterations
are not simply a consequence of neurodegeneration. For
instance, the drug β,β′-iminodiproprionitrile (IDPN) that causes
severe proximal axonopathy does not induce any morphometric
changes of the Golgi in rat motor neurons (Mourelatos et al.,
1994). Furthermore, surgical transection of the rat facial nerve
does not trigger the fine Golgi fragmentation typically observed
in human ALS patients (Fujita et al., 2011). Last, transection
of the sciatic nerve in mice does not alter the cellular levels or
distribution of β-COP, the Golgi tether p115 or the Golgi SNAREs
GS28 and GS15 in the corresponding motor neuron cell bodies
(Bellouze et al., 2014), suggesting that the microtubule/COPI
cross talk is unaffected by axonal injury, in contrast to the
situation in pmnmice.
Conversely, mounting evidence suggests that Golgi alterations
may contribute to, or in some cases even cause, aspects
of motor neuron degeneration. In particular, alterations in
the microtubule/COPI cross talk may impact on the normal
function of the Golgi apparatus in the transport of proteins,
lipids and RNAs that are essential for axon and synapse
maintenance. The COPI subunits α-, β-, and γ-COP for
instance bind numerous mRNAs (Bi et al., 2007; Todd et al.,
2013) and facilitate their axonal transport along microtubules
(Bi et al., 2007). Furthermore, ARF1 function is critical for
axon growth and maintenance (Jareb and Banker, 1997),
suggesting a role of COPI in vesicle biogenesis and/or axonal
transport.
In conclusion, more work is needed to understand the
relevance of Golgi fragmentation for onset and progression
of motor neuron degeneration. One way forward is to
experimentally inhibit Golgi fragmentation in model systems,
whether in vitro or in vivo, and to subsequently assess the
specific consequences on axon degeneration, loss of synaptic
vesicles and synaptic dysfunction. To achieve this, we need
to gain deeper insights into the mechanisms driving this
fragmentation.
Defects in the cross talk between the Golgi microtubule
network and the Golgi transport COPI machinery seem an early
common mechanism shared by human ALS, SMA, and other
motor neuron diseases and thus appear as exciting newmolecular
targets for the development of biomarkers and pharmacological
or gene-based therapies in these severe and currently incurable
disorders.
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